Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c87b3d7ac100dbdc7843d82cb5ae2491 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69a642788870b8f8c739c4d14234884e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac80d3995bfc6c9564dd070367a922c1 |
publicationDate |
2017-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201700107-A |
titleOfInvention |
Use of a pharmaceutical composition for preparing a medicament for inhibiting cerebellar atrophy |
abstract |
The present invention relates to a pharmaceutical composition for the preparation of a medicament for inhibiting cerebellar atrophy, the pharmaceutical composition comprising: paeonia actifloran) and licorice (Glycyrrhizauralensis)n). The pharmaceutical composition has the effects of scavenging free radical activity and inhibiting inflammatory activity, and reducing the aggregation of polyglutamine (polyQ). |
priorityDate |
2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |